European Primary Care Cardiovascular Society
Adults with clinically normal risk factor profiles, who were randomized to a 25% calorie restriction intervention for 2 years, showed improved insulin sensitivity and metabolic syndrome scores.
EuroPrevent 2019 Prof. Hobbs emphasizes the relevance of targeting CVD prevention in diabetic patients and discusses how can we modify CVD risk factors in these patients.
EuroPrevent 2019 Prof. Jacobs discusses the shift in management of diabetes based on CVOTs and explains underlying mechanisms of benefits with GLP-1RAs in diabetic patients.
EuroPrevent 2019 Prof. Deanfield reflects on a new era in CVD prevention for patients with diabetes. He discusses how can we prevent diabetes and manage diabetes exposure in the general population.
In a follow-up study of VADT, original intensive glucose lowing over 5.6 years did not result in improved outcomes in T2DM patients vs. standard-therapy after 15 years, providing no evidence of a legacy effect.
EPCCS 2019 Profs Khunti and Hobbs discuss why CV risk needs attention in patients with diabetes, and how this can be mitigated. They also consider barriers that prevent optimal implementation of the evidence on effective management strategies.
An analysis of the ADVANCE study shows that the treatment effect of perindopril-indapamide in patients with diabetes is independent of SBP, DBP or 10-year ASCVD risk at baseline.
EPCCS 2019 Read impressions of the updates on stroke prevention in AF, hypertension, HF and CV risk in diabetes, with emphasis on challenges faced in patients with multimorbidities.
EPCCS 2019 Slides prepared and presented by prof. Richard Hobbs (Oxford, United Kingdom), here offered as an educational service.
EPCCS 2019 Slides prepared and presented by prof. Kamlesh Khunti (Leicester, UK) here offered as an educational service.
EPCCS 2019 Prof. Hobbs set the scene for the presentation of prof. Khunti, by showing how diabetes is linked to CVD risk, after which prof. Khunti outlined how this risk can best be reduced with therapy.
ACC 2019 The new guideline promotes a healthy lifestyle throughout life, and encourages physicians to assess social determinants of health to optimally implement the recommendations.
